[HTML][HTML] Regulation of PKD by the MAPK p38δ in insulin secretion and glucose homeostasis

G Sumara, I Formentini, S Collins, I Sumara, R Windak… - Cell, 2009 - cell.com
G Sumara, I Formentini, S Collins, I Sumara, R Windak, B Bodenmiller, R Ramracheya…
Cell, 2009cell.com
Dysfunction and loss of insulin-producing pancreatic β cells represent hallmarks of diabetes
mellitus. Here, we show that mice lacking the mitogen-activated protein kinase (MAPK) p38δ
display improved glucose tolerance due to enhanced insulin secretion from pancreatic β
cells. Deletion of p38δ results in pronounced activation of protein kinase D (PKD), the latter
of which we have identified as a pivotal regulator of stimulated insulin exocytosis. p38δ
catalyzes an inhibitory phosphorylation of PKD1, thereby attenuating stimulated insulin …
Summary
Dysfunction and loss of insulin-producing pancreatic β cells represent hallmarks of diabetes mellitus. Here, we show that mice lacking the mitogen-activated protein kinase (MAPK) p38δ display improved glucose tolerance due to enhanced insulin secretion from pancreatic β cells. Deletion of p38δ results in pronounced activation of protein kinase D (PKD), the latter of which we have identified as a pivotal regulator of stimulated insulin exocytosis. p38δ catalyzes an inhibitory phosphorylation of PKD1, thereby attenuating stimulated insulin secretion. In addition, p38δ null mice are protected against high-fat-feeding-induced insulin resistance and oxidative stress-mediated β cell failure. Inhibition of PKD1 reverses enhanced insulin secretion from p38δ-deficient islets and glucose tolerance in p38δ null mice as well as their susceptibility to oxidative stress. In conclusion, the p38δ-PKD pathway integrates regulation of the insulin secretory capacity and survival of pancreatic β cells, pointing to a pivotal role for this pathway in the development of overt diabetes mellitus.
cell.com